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Three errors in concentration units were made during the typesetting of the Materials and Methods section, 2.4. Degradation of
TIMPs by cathepsin B. In three places the character W was wrongly converted to m, so that the section should have been printed as
follows (the corrections have been made in bold):
2.4. Degradation of TIMPs by cathepsin B
The mature form of cathepsin B was a⁄nity-puri¢ed from human kidney [18] and was free of other enzymes as ascertained by
electrophoresis, speci¢city tests with substrates and inhibitors, and N-terminal sequencing. Cathepsin B (containing the pro-form
and the single-chain form) was also prepared from conditioned media of dedi¡erentiated human articular chondrocytes by gel
chromatography [12] followed by ion exchange chromatography on DEAE-Sephacel (Pharmacia). Human recombinant, non-
glycosylated TIMP-1 whose Asn-30 and Asn-78 were mutated to Ala was expressed in CHO K1 cells and puri¢ed on MacroPrep
50Q anion exchange resin (Bio-Rad), Green A Dyematrex (Amicon) and Sephacryl S-200 (Pharmacia). Recombinant human,
glycosylated TIMP-1 was expressed in CHO K1 cells and puri¢ed using anti-(human TIMP-1) a⁄nity chromatography [19].
Human TIMP-2 was puri¢ed from the medium of uterine cervical ¢broblasts [20]. The incubation solutions in 50 mM sodium
acetate bu¡er, 2 mM dithiothreitol, 2 mM EDTA, pH 5.50, contained cathepsin B (5 Wg/ml ¢nal concentration) and recombinant
wild-type or non-glycosylated TIMP-1 (¢nal concentrations in di¡erent experiments 100^160 Wg/ml), or the same cathepsin B
concentration and TIMP-2 (¢nal concentrations in di¡erent experiments 25^57 Wg/ml). Incubation was performed at 30‡C, reaction
was stopped at time intervals by making the solution 2 mM with iodoacetic acid, and the progressive disappearance of the original
protein band followed by SDS-PAGE. After 5 h of incubation the original proteins were completely digested giving a mixture of
peptides. Control experiments included the addition of the cathepsin B-speci¢c inactivator CA-074 at a ¢nal concentration of 1
WM. MALDI-TOF spectra of TIMP-1 and TIMP-2 peptides were accumulated using a Voyager Elite instrumentation (PerSeptive
Biosystems, Framingham, MA, USA) with K-cyano-4-hydroxy-cinnamic acid (5 mg/ml in 50% acetonitrile and 0.1% tri£uoroacetic
acid in water) as the matrix. Samples were analyzed in pulsed extraction re£ectron mode using an acceleration voltage of 20 kV, a
pulse delay time of 75 ns, a grid voltage of 55% and a guide voltage of 0.05%. Peptide sequences matching the determined
molecular masses were calculated with the software PAWS (Protein Analysis WorkSheet) of ProteoMetrics (http://www.proteo-
metrics.com).
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The correct a⁄liations of Sei Kobayashi and Masato Ohmura is given above.
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In the original publication of this paper, the ¢rst three ¢gures were printed in the wrong positions. Whilst the legends were
correct, Fig. 1 was printed as Fig. 2, Fig. 2 was printed as Fig. 3 and Fig. 3 was printed as Fig. 1. The Publisher apologises for this
mistake to author and readers alike.
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